Tumour necrosis factor-α gene expression and production in human umbilical arterial endothelial cells

Clinical Science

Volumn 98, Issue 4, 2000, Pages 461-470

  Neuhaus, Thomas ^a   Totzke, Gudrun ^a   Gruenewald, Elisabeth ^a   Juesten, Hans Peter ^b   Sachinidis, Agapios ^a   Vetter, Hans ^a   Ko, Yon ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Asklepios Klinikum Bad Abbach   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; SEPTIC SHOCK; SOUTHERN BLOTTING; UMBILICAL ARTERY;

EID: 0034090487     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0980461     Document Type: Article

References (63)

1. 1 Chen, C. C. and Manning, A. M. (1996) TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 8, 58-65
2. 2 Li, Y., Stechschulte, A. C., Smith, D. D., Lindsley, H. B., Stechschulte, D. J. and Dileepan, K. N. (1997) Mast cell granules potentiate endotoxin-induced interleukin-6 production by endothelial cells. J. Leukocyte Biol. 62, 210-216
3. 3 Miossec, P., Cavender, D. and Ziff, M. (1986) Production of interleukin-1 by human endothelial cells. J. Immunol. 136, 2486-2491
4. 4 Munoz, C., Pascual-Salcedo, D., Castellanos, M. et al. (1996) Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-κB and AP-1 transcription factor activity. Blood 88, 3482-3490
5. 5 Saegusa, Y., Ziff, M., Welkovich, L. and Cavender, D. (1990) Effect of inflammatory cytokines on human endothelial cell proliferation. J. Cell. Physiol. 142, 488-495
6. 6 Cotran, R. S. and Pober, J. S. (1989) Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int. 35, 969-975
7. 7 Holzinger, C., Weissinger, E., Zuckermann, A. et al. (1993) Effects of interleukin-1, -2, -4, -6, interferon-γ and granulocyte/macrophage colony stimulating factor on human vascular endothelial cells. Immunol. Lett. 35, 109-118
8. 8 Bevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S. and Gimbrone, Jr., M. A. (1985) Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J. Clin. Invest. 76, 2003-2011
9. 9 Lenhoff, S. and Olofsson, T. (1996) Cytokine regulation of GM-CSF and G-CSF secretion by human umbilical cord vein endothelial cells (HUVEC). Cytokine 8, 702-709
10. 10 Endo, H., Akahoshi, T. and Kashiwazaki, S. (1988) Additive effects of IL-1 and TNF on induction of prostacyclin synthesis in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 156, 1007-1014
11. 11 Ristimaeki, A. and Viinikka, L. (1992) Modulation of prostacyclin production by cytokines in vascular endothelial cells. Prostaglandins Leukotrienes Essential Fatty Acids 47, 93-99
12. 12 Royall, J. A., Berkow, R. L., Beckmann, J. S., Cunningham, M. K., Matalon, S. and Freeman, B. A. (1989) Tumor necrosis factor and interleukin-1α increase vascular endothelial permeability. Am. J. Physiol. 257, L399-L410
13. 13 Paleolog, E. M., Aluri, G. R. and Feldmann, M. (1992) Contrasting effects of interferon-γ and interleukin-4 on responses of human vascular endothelial cells to tumor necrosis factor-α. Cytokine 4, 470-478
14. 14 Thornhill, M. H. and Haskard, D. O. (1990) IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-γ. J. Immunol. 145, 865-872
15. 15 Kapadia, S., Lee, J., Torre-Amione, G., Birdsall, H. H., Ma, T. S. and Mann, D. L. (1995) Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J. Clin. Invest. 96, 1042-1052
16. 16 Tracey, K. J., Vlassara, H. and Cerami, A. (1989) Cachectin/tumor necrosis factor. Lancet i, 1122-1126
17. 17 Warner, S. J. C. and Libby, P. (1989) Human vascular smooth muscle cells; target for and source of tumor necrosis factor. J. Immunol. 142, 100-109
18. 18 Giroir, B. P., Johnson, J. H., Brown, T., Allen, G. L. and Beutler, B. (1992) The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J. Clin. Invest. 90, 693-698
19. 19 Kapadia, S. R., Oral, H., Lee, J., Nakano, M., Taffet, G. E. and Mann, D. L. (1997) Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium. Circ. Res. 81, 187-195
20. 20 Kita, T., Tanaka, N. and Nagano, T. (1993) The immunocytochemical localization of tumour necrosis factor and leukotriene in the rat kidney after treatment with lipopolysaccharide. Int. J. Exp. Pathol. 74, 471-479
21. 21 Ulich, T. R., Guo, K. and del Castillho, J. (1989) Endotoxin-induced cytokine gene expression in vivo. Am. J. Pathol. 134, 11-14
22. 22 Luster, M. I., Germolec, D. R., Yoshida, T., Kayama, F. and Thompson, M. (1994) Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19, 480-488
23. 23 Rosenblum, M. G. and Donato, N. J. (1989) Tumor necrosis factor α: A multifaceted peptide protein. Crit. Rev. Immunol. 9, 21-44
24. 24 Nagate, S. (1997) Apoptosis by death factor. Cell 88, 355-365
25. 25 Levine, B., Kalman, J., Mayer, L., Fillit, H. M. and Packer, M. (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236-241
26. 26 Odeh, M. (1990) The role of tumor necrosis factor-α in acquired immunodeficiency syndrome. J. Intern. Med. 228, 549-556
27. 27 Beutler, B. and Cerami, A. (1986) Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature (London) 320, 584-588
28. 28 Barath, P., Fishbein, M. C., Cao, J., Berenson, J., Helfant, R. H. and Forrester, J. S. (1990) Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 65, 297-302
29. 29 Glauser, M. P., Zanetti, G., Baumgartner, J.-D. and Cohen, J. (1991) Septic shock: pathogenesis. Lancet 338, 732-739
30. 30 Parrillo, J. E. (1990) Septic shock in humans. Ann. Intern. Med. 113, 227-242
31. 31 Tracey, K. J., Fong, Y., Hesse, D. G. et al. (1987) Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (London) 330, 662-664
32. 32 Mathison, J. C., Wolfson, E. and Ulevitch, R. J. (1988) Participation of tumor necrosis factor in the mediation of Gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81, 1925-1937
33. 33 Calandra, T., Baumgartner, J.-D., Grau, G. E. et al. and the Swiss-Dutch J5 Immunoglobulin Study Group. (1990) Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J. Infect. Dis. 161, 982-987
34. 34 Casey, L. C., Balk, R. A. and Bone, R. C. (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119, 771-778
35. 35 Abraham, E., Anzueto, A., Gutierrez, G. et al. (1998) Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. Lancet 351, 929-933
36. 36 Fisher, Jr., C. J., Agosti, J. M., Opal, S. M. et al. (1996) Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The soluble TNF receptor sepsis study group. N. Engl. J. Med. 334, 1697-1702
37. 37 Shanahan, Jr., W. R., Hancock, W. W. and Korn, J. H. (1989) Expression of IL-1 and tumor necrosis factor by endothelial cells: role in stimulating fibroblast PGE2 synthesis. J. Exp. Pathol. 4, 17-27
38. 38 Sparrow, D. G., Gard, S., Buret, A., Ceri, H., Olson, M. and Morck, D. W. (1997) Expression of tumor necrosis factor a and granulocyte-macrophage colony stimulating factor by bovine endothelial cells in vitro. Clin. Infect. Dis. 25 (Suppl. 2), S178-S179
39. 39 Ko, Y., Totzke, G., Schiermeyer, B. et al. (1995) Reverse transcriptase/polymerase chain reaction (RT/PCR): a sensitive method to examine basic fibroblast growth factor-induced expression of the early growth response gene-1 (egr-1) in human umbilical arterial endothelial cells. Mol. Cell. Probes 9, 215-222
40. 40 Ko, Y., Totzke, G., Seewald, S. et al. (1995) Native low-density lipoprotein (LDL) induces the expression of the early-growth response gene-1 in human arterial endothelial cells. Eur. J. Cell Biol. 68, 306-312
41. 41 Mullis, K. B. and Faloona, F. A. (1987) Specific synthesis of DNA in vitro via the polymerase-catalyzed chain reaction. Methods Enzymol. 155, 335-350
42. 42 Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd edn, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
43. 43 Schwonzen, M., Pohl, C., Steinmetz, T., Wickramanayake, P. D., Thiele, J. and Diehl, V. (1992) Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology. Br. J. Haematol. 81, 362-369
44. 44 Taffet, S. M., Singhel, K. J., Overholtxer, J. F. and Shurtleff, S. A. (1989) Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccharide and cyclic AMP. Cell. Immunol. 120, 291-300
45. 45 Zhong, W. W., Burke, P. A., Hand, A. T., Walsh, M. J., Hughes, L. A. and Forse, R. A. (1993) Regulation of cytokine mRNA expression in lipopolysaccharide-stimulated human macrophages. Arch. Surg. 128, 158-163
46. 46 Beutler, B., Krochin, N., Milsark, I. W., Luedke, C. and Cerami, A. (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232, 977-980
47. 47 Tovey, M. G., Contnet, J., Gresser, I. et al. (1988) Genes for IFN-β2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. J. Immunol. 141, 3106-3110
48. 48 Appel, K., Honegger, P. and Gebicke-Haerter, P. J. (1995) Expression of interleukin-3 and tumor necrosis factor-β mRNAs in cultured microglia. J. Neuroimmunol. 60, 83-91
49. 49 DeForge, L. E. and Remick, D. G. (1991) Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem. Biophys. Res. Commun. 174, 18-24
50. 50 Kohn, F. R., Philips, G. L. and Klingemann, H. G. (1992) Regulation of tumor necrosis factor-α production and gene expression in monocytes. Bone Marrow Transplant. 9, 369-376
51. 51 Velasco, S., Tarlow, M., Olsen, K., Shay, J. W., McCracken, G. H. and Nisen, P. D. (1991) Temperature-dependent modulation of lipopolysaccharide-induced interieukin-1β and tumor necrosis factor α expression in cultured human astroglial cells by dexamethasone and indomethacin. J. Clin. Invest. 87, 1674-1680
52. 52 Vilcek, J. and Lee, T. H. (1991) Tumor necrosis factor. J. Biol. Chem. 266, 7313-7316
53. 53 Han, J., Brown, T. and Beutler, B. (1990) Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171, 465-475
54. 54 Epstein, F. H. (1987) Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316, 379-385
55. 55 Descoteaux, A. and Matlashewski, G. (1990) Regulation of tumor necrosis factor gene expression and protein synthesis in murine macrophages treated with recombinant tumor necrosis factor. J. Immunol. 145, 846-853
56. 56 Leithauser, M. L., Rob, P. M. and Sack, K. (1997) Pentoxifylline, cyclosporine A and taurolidine inhibit endotoxin-stimulated tumor necrosis factor-α production in rat mesangial cell cultures. Exp. Nephrol. 5, 100-104
57. 57 Beutler, B., Greenwald, D., Hulmes, J. D. et al. (1985) Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature (London) 316, 552-554
58. 58 Tiegs, G., Barsig, J., Matiba, B., Uhlig, S. and Wendel, A. (1994) Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice. J. Clin. Invest. 93, 2616-2622
59. 59 Shapira, L., Soskolne, W. A., Houri, Y., Barak, V., Halabi, A. and Stabholz, A. (1996) Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect. Immun. 64, 825-828
60. 60 Fromm, R. E., Suffredini, A. F., Kovacs, J. A., Schlesinger, T. and Parrillo, J. E. (1988) Serum tumor necrosis factor response in humans receiving endotoxin. Clin. Res. 36, 372A
61. 61 Michie, H. R., Manogue, K. R., Spriggs, D. R. et al. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318, 1481-1486
62. 62 Suffredini, A. F., Fromm, R. E., Parker, M. M. et al. (1989) The cardiovascular response of normal humans to the administration of endotoxin. N. Engl. J. Med. 321, 280-287
63. 63 Damas, P., Reuter, A., Gysen, P., Demonty, J., Lamy, M. and Franchimont, P. (1989) Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit. Care Med. 17, 975-978